LIGAND PHARMACEUTICALS INC (LGND) Current Reports & Earnings Releases
Upcoming
- 2026-11-05 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-14 | 8-K | Material Agreement, Acquisition or Disposition, Direct Financial Obligation, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-25 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-22 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-09 | 8-K | Officer / Director Changes, Shareholder Vote Results | SEC |
| 2026-05-18 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-30 | 8-K | Termination of Agreement | SEC |
| 2026-04-27 | 8-K | Material Agreement, Other Events | SEC |
| 2026-02-26 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-12-18 | 8-K | Reg FD Disclosure | SEC |
| 2025-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-09-16 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2025-08-14 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-11 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-07-02 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-06-09 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-04-17 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-02-27 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-02-25 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-11-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-02 | 8-K | Officer / Director Changes | SEC |
| 2024-07-17 | 8-K | Acquisition or Disposition | SEC |
| 2024-07-10 | 8-K | Material Agreement, Direct Financial Obligation | SEC |
| 2024-07-08 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-06-27 | 8-K | Other Events | SEC |
| 2024-06-18 | 8-K | Other Events | SEC |
| 2024-06-17 | 8-K | Officer / Director Changes, Shareholder Vote Results | SEC |
| 2024-05-30 | 8-K | Other Events | SEC |
| 2024-05-07 | 8-K | Material Agreement | SEC |
| 2024-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-19 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2024-02-27 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-01-08 | 8-K | Other Events | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.